Withdrawal: Clinical Trials

11 trials for Withdrawal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 unknown, 1 recruiting. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 22Completed 1, Unknown 1
Early Phase 11Recruiting 1
Phase 11Unknown 1
Phase 31Unknown 1

Follow Withdrawal: new trials by email Literature Review of Withdrawal trials Research Report on Withdrawal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Electronic Cigarette Withdrawal Syndrome
Transdermal Nicotine Patch, Placebo Nicotine Patch - E-cigarette Use, Withdrawal
Early Phase 1RecruitingJohns Hopkins University1502023-11-282026-07-15
Effect of Diuretics Withdrawal in Chronic Heart Failure With Reduced Ejection Fraction
Diuretics withdrawal, Diuretics maintenance - Heart Failure, Electric Impedance
Phase 2CompletedMaimónides Biomedical Research Institute of Córdoba982022-12-192024-11-04
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
Prednisolone, Sulfasalazine, Leflunomide - Psoriatic Arthritis, Withdrawal
Phase 3UnknownUniversity of Erlangen-Nürnberg Medical School2702020-10-192022-11-14
Evaluation of the Management of Tramadol Use Disorders
Withdrawal
CompletedUniversity Hospital, Montpellier502020-09-172021-10-25
Feasibility of Auricular Acupressure as an Adjunct Treatment for Neonatal Abstinence Syndrome (NAS)
Auricular acupuncture - Neonatal Abstinence Syndrome, Withdrawal
Not applicableCompletedVanderbilt University Medical Center122019-08-192020-03-10
The Biobehavioral Impact of Diet Quality on Affect and Craving
Dietary Change (low in highly processed foods) - Food Addiction, Withdrawal
Not applicableCompletedUniversity of Michigan682019-06-182021-11-01
Opioid Physiology Project
Tolerance, Withdrawal
CompletedUniversity of Tennessee872017-08-142018-10-11
Evaluation of the Effect of Venous Diameter Measurement by Ultrasonography on Pain and Withdrawal Response
Pain Score, Withdrawal movement score, hemodynamic response - Pain, Withdrawal
CompletedAydin Adnan Menderes University1452017-06-012017-12-19
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
BZDs + opiate exposure treated with BPN, Opiates exposure treated with BPN - Drug; Withdrawal Symptoms, Neonatal, Withdrawal
Phase 1 / Phase 2UnknownGauda, Estelle B., M.D.402014-10-012016-05-06
Terminal Weaning of Mechanical Ventilation or Extubation in Anticipation of Death in the Intensive Care Unit
Withdrawal, Anxiety
CompletedCentre Hospitalier Departemental Vendee4582013-04-012015-07-10
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06

Narrower conditions

Anxiety Disorders (2)  ·  Heart Failure (2)  ·  Pain (2)  ·  Adenoviridae Infections (1)  ·  Arrhythmias, Cardiac (1)  ·  Arthritis, Psoriatic (1)  ·  Autistic Disorder (1)  ·  Behavior, Addictive (1)  ·  Bipolar Disorder (1)  ·  Bradycardia (1)  ·  Central Nervous System Infections (1)  ·  Cytomegalovirus Retinitis (1)  ·  Death (1)  ·  Depression (1)  ·  Dyspnea (1)

Broader conditions

Mental Disorders (6)  ·  Behavior (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Chemically-Induced Disorders (3)  ·  Signs and Symptoms (3)  ·  Cardiovascular Diseases (2)  ·  Compulsive Behavior (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Heart Diseases (2)  ·  Impulsive Behavior (2)  ·  Neurologic Manifestations (2)  ·  Pathologic Processes (2)  ·  Respiratory Tract Diseases (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Abatacept (1)  ·  Acupuncture, Ear (1)  ·  Adalimumab (1)  ·  Alfentanil (1)  ·  Amikacin (1)  ·  Aminocaproic Acid (1)  ·  Bosentan (1)  ·  Buprenorphine (1)  ·  Buprenorphine, Naloxone Drug Combination (1)  ·  Cefepime (1)  ·  Certolizumab Pegol (1)  ·  Cidofovir (1)  ·  Ciprofloxacin (1)  ·  Clozapine (1)  ·  Etanercept (1)

Sponsors

Aydin Adnan Menderes University (1)  ·  Centre Hospitalier Departemental Vendee (1)  ·  Daniel Benjamin (1)  ·  Gauda, Estelle B., M.D. (1)  ·  Johns Hopkins University (1)  ·  Maimónides Biomedical Research Institute of Córdoba (1)  ·  University Hospital, Montpellier (1)  ·  University of Erlangen-Nürnberg Medical School (1)  ·  University of Michigan (1)  ·  University of Tennessee (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (6)  ·  France (2)  ·  Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Singapore (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Alberto Torres Zamudio, MD (1)  ·  Ashley Gearhardt, Ph.D (1)  ·  Chi Hornik, PharmD (1)  ·  Estelle B Gauda, MD (1)  ·  Heather Jackson, MSN (1)  ·  Jean Reignier, MD, PhD (1)  ·  Justin Strickland, Ph.D. (1)  ·  Karen J Derefinko, PhD (1)

Results publications

PMID 21791539, PMID 24614374, PMID 24949994, PMID 25176015, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28390780, PMID 28779462, PMID 28936597, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30741494, PMID 30790601, PMID 31317556, PMID 31424503, PMID 31548185, PMID 31814149, PMID 32171764, PMID 32324313, PMID 32497307, PMID 32673497, PMID 33029806, PMID 33736819, PMID 33903114, PMID 34270522, PMID 34302290, PMID 34447992, PMID 35370711, PMID 35491971, PMID 41247430

NIH funding

R01DA057925 (1)